Armistice Capital »

Udr shares owned by Armistice Capital

Quarter-by-quarter ownership of Udr (UDR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Udr

Tip: Access up to 7 years of quarterly data

All positions including Udr held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Udr by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $217k 5.4k 39.92

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Udr

BlackRock
Norges Bank Investment Management
Capital Research Global Investors
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Cohen & Steers Capital Management
FMR
Invesco
Centersquare Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Canada Pension Plan Investment Board
Wellington Management Company
Charles Schwab Investment Management

View all funds holding Udr